RYZ heads into the week's close with a fresh earnings print in hand — one that splits the headline neatly between a bottom-line beat and a top-line miss.
Q1 2026 adjusted EPS came in at $0.30, clearing the $0.28 consensus. Revenue, however, landed at $1.567 billion against expectations of $1.699 billion — a miss of roughly 8%. Ryerson guided Q2 same-store daily shipments to grow 1%–3% sequentially, framing that as consistent with normal seasonality. The stock was already running hard coming into the print — up 25.8% over the prior month and 4.7% on the week — so the earnings release landed into a market that had already re-rated the name meaningfully higher. The prior quarter print, reported in February, produced a 17.8% one-day pop and a 9.5% five-day follow-through; the most recent event on April 30 delivered a 4.4% gain. The pattern of upside post-results is consistent, even when revenue underwhelms.
Short interest tells a measured story here, neither crowded nor in retreat. SI runs at 5.1% of the free float — meaningful, but drifting lower. It has fallen roughly 11% over the past month, with the sharpest step-down coming around April 10 when SI dropped from ~1.85 million shares to ~1.81 million, coinciding with a period of broader market stress. Borrow costs reflect the same lack of conviction among short sellers: cost to borrow has eased nearly 19% over the week to around 0.51%, and has been largely range-bound between 0.40% and 0.63% since late March. Availability in the lending market is loose — the borrow market is simply not under pressure, which means there is no meaningful short-squeeze dynamic at work here. The ORTEX short score of 36.8 (on a 0-100 scale where higher implies more bearish positioning) has been almost perfectly flat for the past two weeks, reinforcing the picture of short-side stasis rather than building pressure.
Options positioning remains calm and slightly call-skewed, which is consistent with the bullish month the stock has had. The put/call ratio is running at 0.38, a touch above the 20-day mean of 0.35, but the z-score of just 0.41 signals nothing out of the ordinary. The 52-week PCR high is 0.48 — the current reading is well below that. Traders are not scrambling for downside protection, and that calm has persisted through the earnings event.
On the Street, formal analyst data is limited and stale — the most recent on-record action is a Keybanc initiation from March 25 at "Sector Weight" with no price target attached. The mean price target from available data is $27.00, essentially in line with the $27.90 close as of May 5, which suggests that if analyst coverage has not been refreshed since the February earnings rally, the Street consensus is already trading below current price levels. The EPS surprise factor score of 85 (85th percentile) supports the view that Ryerson has been a consistent beat. Dividend data is stale — the last disclosed distribution was in mid-2022 — and should not be read as current.
Institutional ownership tells an interesting sub-story. Several large holders have been adding meaningfully. State Street increased its position by over 730,000 shares in the most recent quarter, American Century added roughly 828,000, and Vanguard added around 540,000. Dimensional Fund Advisors added approximately 329,000 shares. BlackRock, the second-largest institutional holder at 6.6% of shares, also added roughly 383,000. That broad-based accumulation pattern is notable, particularly given that some of these filings carry April 30 dates — meaning they reflect buying during the recent period of market turbulence. On the insider side, the March 31 activity was dominated by compensation awards to the CEO, CFO, and Chief Accounting Officer. The CFO also sold 10,415 shares at $22.48, locking in gains well below the current price. Net insider activity over 90 days is positive at roughly $3.2 million, though much of that reflects award valuations rather than open-market purchases.
Peers in the steel distribution and processing space moved largely in lockstep this week. STLD gained 4.6% on the week, WS added 6.9%, and CLF rose 4.2% — all participating in what has been a broad sector re-rating. RYZ's 4.7% weekly gain keeps it in step with the group, so the move does not appear idiosyncratic; the sector tailwind has been real. What makes the Q2 guidance read the most important next waypoint: same-store shipment growth coming in above or below that 1%–3% seasonal range will tell the market whether the volume story is improving or simply running with the cycle.
See the live data behind this article on ORTEX.
Open RYZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
